相关实验视频

Updated: Jun 13, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

一个新型的强效抗血管原和抗氧化剂pyrazoles类别:合成,生物活性,对接和ADMET研究

Siddaram Nadigar¹, Rohith Gattu¹, Sanjay Ramesh¹

¹Postgraduate Department of Chemistry, JSS College of Arts, Commerce & Science (a recognized Research Centre of University of Mysore), Ooty Road, Mysuru-25, Karnataka, India.

Future medicinal chemistry

|September 12, 2024

概括

新型Pyrazoles通过抑制VEGF/VEGFR-2通路显示出强大的抗血管和抗氧化作用. 这些化合物显示出作为癌症治疗的希望,因为它们具有有利的类似药物的特性和瘤生长抑制的潜力.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

血管新生是由VEGF/VEGFR-2通路驱动的,对于瘤生长和转移至关重要.
抑制血管生成是开发抗癌疗法的关键策略.
需要新的小分子来有效地准这种途径.

研究的目的:

合成和评估一种新的类型的pyrazole衍生品,以检测它们的抗血管和抗氧化作用.
为了研究这些pyrazoles与VEGFR-2受体和VEGF氨酸激酶的结合潜力.
评估合成化合物的药物相似性和ADMET特性.

主要方法:

从氨酸和双基中合成pyrazole衍生物.
在体内使用黄囊方法进行抗血管原体检测.
在体外抗氧化剂测试 (氧化和超氧化基清除).
针对VEGFR-2和VEGF氨酸激酶的分子对接研究.
在 silico ADMET 预测使用 SwissADME 和 admetSAR.

主要成果:

化合物5a-e表现出显著的抗血管性活性.
化合物5f表现出强大的基和超氧化基清除能力.
接研究表明,与VEGFR-2的优先结合,表明具有竞争性抑制.
在中ADMET分析证实了测试的Pyrazoles具有有利的类似药物的特性.

结论:

新型皮拉衍生物具有显著的抗氧化剂和抗血管性潜力.
这些化合物通过向VEGFR-2通路来有效抑制血管生成.
良好的药物相似性表明它们有潜力作为癌症治疗的治疗剂.

关键词:

抗血管生成是一种反血管生成.抗氧化剂抗氧化剂是一种抗氧化剂.在阿根廷,阿根廷人.分子对接的分子对接.这些是Pyrazoles.

更多相关视频

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Synthesis of pH Dependent Pyrazole, Imidazole, and Isoindolone Dipyrrinone Fluorophores using a Claisen-Schmidt Condensation Approach

Published on: June 10, 2021

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...